PPARA and metabolic dysfunction-associated steatotic liver disease: Numerous studies have been designed to activate PPARA for slowing the progression or curing NAFLD, and they demonstrate enhancement in metabolic activity and decrease of steatosis and fibrosis in NAFLD patients and models [48,55,56,57].